OvaScience Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
OvaScience is a biotechnology company focused on developing treatments for infertility in women and families. It is based in Waltham, Massachusetts, and relies on a platform built around immature egg cells called EggPC cells found in the ovarian cortex. The company is pursuing several fertility therapies, including OvaPrime to potentially restore a woman's egg production and OvaTure to enable IVF without hormone stimulation, while AUGMENT aims to improve fertilization and pregnancy rates. AUGMENT is available in Japan under an exclusive license to IVF Japan, and the company’s therapies are not available in the United States. Positioned in the biotechnology research sector, OvaScience describes itself as a smaller to mid-sized organization focused on discovery and development of fertility treatments.